Calithera Biosciences, Inc. (CALA)
OTCMKTS
· Delayed Price · Currency is USD
0.0006
-0.0094 (-94.00%)
Feb 18, 2025, 3:00 PM EST
Calithera Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2013 |
|---|---|---|---|---|---|---|
Period Ending | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2013 |
| Cash & Equivalents | 25.45 | 59.54 | 107.15 | 60.44 | 51.06 | Upgrade
|
| Short-Term Investments | - | - | 8.01 | 96.92 | 85.1 | Upgrade
|
| Cash & Short-Term Investments | 25.45 | 59.54 | 115.15 | 157.36 | 136.15 | Upgrade
|
| Cash Growth | -57.25% | -48.30% | -26.82% | 15.58% | -16.87% | Upgrade
|
| Accounts Receivable | - | - | - | - | 2 | Upgrade
|
| Other Receivables | - | - | 1.54 | 0.48 | - | Upgrade
|
| Receivables | - | - | 1.54 | 0.48 | 2 | Upgrade
|
| Prepaid Expenses | 1.17 | 1.92 | 2.01 | 1.95 | 2.1 | Upgrade
|
| Total Current Assets | 26.62 | 61.45 | 118.7 | 159.8 | 140.25 | Upgrade
|
| Property, Plant & Equipment | 1.78 | 3.03 | 6.44 | 8.25 | 1.46 | Upgrade
|
| Other Long-Term Assets | 0.27 | 0.27 | 0.44 | 0.72 | 1.01 | Upgrade
|
| Total Assets | 28.68 | 64.76 | 125.59 | 168.77 | 142.73 | Upgrade
|
| Accounts Payable | 0.73 | 3.65 | 1.99 | 2.05 | 1.25 | Upgrade
|
| Accrued Expenses | 4.94 | 8.94 | 13.05 | 13.32 | 11.17 | Upgrade
|
| Current Portion of Leases | 1.53 | 1.37 | 1.9 | 1.48 | - | Upgrade
|
| Other Current Liabilities | 0.19 | 0.05 | 1.45 | 2.78 | 2.47 | Upgrade
|
| Total Current Liabilities | 7.39 | 14.01 | 18.4 | 19.62 | 14.88 | Upgrade
|
| Long-Term Leases | 0.14 | 1.67 | 4.82 | 6.72 | - | Upgrade
|
| Other Long-Term Liabilities | 0.76 | - | - | - | 1.13 | Upgrade
|
| Total Liabilities | 8.28 | 15.67 | 23.22 | 26.34 | 16.01 | Upgrade
|
| Common Stock | - | - | 0.01 | 0.01 | 0 | Upgrade
|
| Additional Paid-In Capital | 510.67 | 499.71 | 478.6 | 428.48 | 322.99 | Upgrade
|
| Retained Earnings | -512.62 | -491.33 | -376.24 | -286.1 | -196.17 | Upgrade
|
| Comprehensive Income & Other | - | - | 0 | 0.04 | -0.11 | Upgrade
|
| Total Common Equity | -1.95 | 8.38 | 102.37 | 142.43 | 126.71 | Upgrade
|
| Shareholders' Equity | 20.39 | 49.08 | 102.37 | 142.43 | 126.71 | Upgrade
|
| Total Liabilities & Equity | 28.68 | 64.76 | 125.59 | 168.77 | 142.73 | Upgrade
|
| Total Debt | 1.67 | 3.04 | 6.72 | 8.2 | - | Upgrade
|
| Net Cash (Debt) | 23.79 | 56.5 | 108.43 | 149.17 | 136.15 | Upgrade
|
| Net Cash Growth | -57.90% | -47.90% | -27.31% | 9.56% | -16.87% | Upgrade
|
| Net Cash Per Share | 4.76 | 15.30 | 31.51 | 63.06 | 74.39 | Upgrade
|
| Filing Date Shares Outstanding | 4.87 | 3.94 | 3.67 | 3.23 | 1.94 | Upgrade
|
| Total Common Shares Outstanding | 4.87 | 3.86 | 3.53 | 3.18 | 1.94 | Upgrade
|
| Working Capital | 19.23 | 47.45 | 100.3 | 140.17 | 125.37 | Upgrade
|
| Book Value Per Share | -0.40 | 2.17 | 28.96 | 44.85 | 65.26 | Upgrade
|
| Tangible Book Value | -1.95 | 8.38 | 102.37 | 142.43 | 126.71 | Upgrade
|
| Tangible Book Value Per Share | -0.40 | 2.17 | 28.96 | 44.85 | 65.26 | Upgrade
|
| Machinery | 2.65 | 2.54 | 2.79 | 2.88 | 2.89 | Upgrade
|
| Leasehold Improvements | 1.23 | 1.23 | 1.23 | 1.23 | 1.23 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.